Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...
Production Resource Group ("PRG" or "the Company"), a leading global provider of entertainment and live event technology ...
Adverse childhood experiences and traumatic events experienced or witnessed at any point during one's lifetime can sometimes ...
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...
Discusses Accelerating Generative AI Adoption in Telecom With Purpose-Built Agentic Operating System March 23, 2026 2:00 PM ...
Hello, everyone, and welcome to the Innoviz Physical AI webinar. Before we get started, I would like to remind you that our discussion today will include forward-looking statements that are subject to ...
By growing miniature brain models from patient cells, researchers have identified distinct electrical activity patterns ...
AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
Beneath the highly visible yet often counterproductive AI consumption race lies a far more consequential one: the race for AI ...
PLC (NASDAQ:SMX) is advancing the way rare earth elements and precious metals are authenticated, tracked, and managed – ...
Understanding the type of arthritis, its causes, and management options is the first step toward living well with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results